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Aim: In recent years, tularemia’s importance has been reemerging in Turkey. However, the majority of tularemia cases were reported in
the northern cities of Turkey. In this study, we report 16 oropharyngeal tularemia patients living in rural areas of the city of Konya, which
is located in the southern zone of the Central Anatolia Region of Turkey.
Materials and methods: Sixteen patients (12 males, 4 females; mean age: 33.7 years, range: 10–73 years) were included in this study. All
patients were admitted to our clinic for the evaluation of intractable cervical mass lesions. The diagnosis of tularemia was made after
exclusion of other possible causes of the neck masses and the presence of a positive tularemia agglutination test. Each patient was treated
with streptomycin and doxycycline for at least 3 weeks.
Results: All patients suffered oropharyngeal stiffness. There were neck mass and tonsillitis on the same side in 2 patients, neck mass
and acute pharyngitis in 3 patients, and only swelling in the neck region in 11 patients. One of the patients with tonsillitis had common
maculopapular skin rashes with fever. Thirteen patients had mass at level 2 zones, 11 patients had mass on the right side of the neck, and
5 patients had mass on the left side of the neck. The right parotid gland was involved in 1 patient. Nine patients were successfully treated
with only antimicrobial agents. Lymph node excision was performed in 6 patients, and parotidectomy was performed in 1 patient.
Conclusion: This is the second series of tularemia from the city of Konya in Turkey. Tularemia should be considered in the differential
diagnosis of patients with intractable neck mass, because early diagnosis and treatment may prevent surgical interventions.
Key words: Tularemia, neck mass, surgery

1. Introduction
Tularemia is a zoonotic disease caused by Francisella
tularensis, which is a pathogen of mainly gnawing animals
(1,2). It was first identified in the city of Tulare, CA,
USA, approximately 100 years ago. Although tularemia
outbreaks have been reported in many parts of the northern
hemisphere, it was generally regarded as a rare disease in
most other areas. Depending on the route of microbial
transmission, different clinical forms of tularemia can be
seen, including ulceroglandular, glandular, pneumonic,
oropharyngeal, oculoglandular, and systemic (typhoidal)
forms. Tularemia is transmitted mainly by insect bites,
contact with infected animals, or consumption of
contaminated animal products and/or water.
The first tularemia outbreak was reported in Turkey in
1936 (4). However, in recent years, an increasing number of
tularemia cases have been reported in different regions of
Turkey, and it has become a reemerging situation (5,6). The
majority of tularemia cases were reported in the northern
* Correspondence: mtezer2000@yahoo.com

cities of Turkey, including Samsun, Kocaeli, Sakarya,
Tokat, Edirne, and Bursa (2,3,7–10). In Turkey, waterborne
outbreaks are responsible for many cases. Accordingly, the
oropharyngeal form is more common in Turkey (2,6,7,11–
13). In the oropharyngeal form, intractable mass lesions in
the cervical region are a frequent finding (3,7,14), which
makes tularemia an important differential diagnosis for
such lesions in recent years.
To our knowledge, only 3 studies were reported from
Central Anatolia. However, those studies were reported
from university hospitals, which were tertiary reference
centers for Central Anatolia. In one of those studies, the
authors wrote that the patients were from Çorum, which is
located in the northern zone of Central Anatolia (6). In the
second study, the authors reported that the patients were
living in the Central Anatolia Region of Turkey without
specifying the exact origin of the patients (5). In this study,
we report the clinical features, management strategies,
and outcomes of 16 oropharyngeal tularemia patients
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who were admitted to a single otorhinolaryngology clinic
for the evaluation of intractable cervical mass lesions. All
patients were living in rural areas of the city of Konya,
which is located in the southern zone of the Central
Anatolia Region of Turkey. To the best of our knowledge,
this is the second study on tularemia cases in the city of
Konya.
2. Materials and methods
This study was performed in the Otorhinolaryngology
Clinic of the Ministry of Health Konya Training and
Research Hospital. Sixteen patients (12 males, 4 females)
who were admitted to our clinic with the complaint of
swelling in the neck region between 2010 and 2012 were
included in this study. The mean age of the patients was
33.7 years (range: 10–73). Mean duration of symptoms
before admission to our clinic was 3–4 weeks (range:
1–8). Each patient was evaluated with an ear, nose,
throat, head, and neck examination, followed by an
endoscopic examination. Complete blood cell count,
erythrocyte sedimentation rate, C reactive protein levels,
and serological tests for human immunodeficiency
virus, Epstein–Barr virus, cytomegalovirus, Toxoplasma,
and Brucella were also performed. Chest radiography,
tuberculin skin test, acid-fast staining, and tuberculosis
culture of sputum were done. The neck mass of each patient
was evaluated by ultrasonography, magnetic resonance
imaging, and/or computerized tomography of the neck.
Serum samples from each patient for the serological
evaluation of tularemia were sent to the Refik Saydam
Public Hygiene Center, which is a reference laboratory for
the evaluation of infectious diseases, including tularemia,
in Turkey. The diagnosis of tularemia was made after
exclusion of other possible causes of the neck masses,
including tuberculosis and malignancy, and the presence
of a positive tularemia agglutination test. Antibody titers of
≥1:160 were accepted as positive for the disease. According
to the recommendations of the Department of Infectious
Diseases, each patient was treated with intramuscular
streptomycin (1 g, twice daily) and doxycycline (100 mg,
twice daily) for at least 3 weeks. The dose of streptomycin
was calculated as 2 × 15 mg/kg for pediatric patients.
3. Results
All patients were admitted with the complaint of an
intractable cervical mass. All had previously been treated
with oral and/or a penicillin/cephalosporin group of
antibiotics in different medical centers. All of the patients
applied in spring and summer months (May–August).
None of the patients had a history of hunting or contact
with wild animals. Only 2 of the patients were from the
same family. All of them were living in rural areas of the
city of Konya.
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The ear, nose, throat, and head and neck examinations
revealed a mass and tonsillitis on the same side in 2
patients, a neck mass and acute pharyngitis in 3 patients,
and only swelling in the neck region in 11 patients. One of
the patients with tonsillitis had common maculopapular
skin rashes with a fever (Table). All patients suffered from
an oropharyngeal mass (Figure). Thirteen patients had a
mass at level 2 zones, 11 patients had mass on the right
side of the neck, and 5 patients had mass on the left side of
the neck. The right parotid gland was involved in 1 patient
(Table).
Patients’ laboratory findings were checked during
initial admissions and followed during the hospitalization
periods. The mean white blood cell (WBC) count was
11,800/mm3 (8300–17,500/mm3). Ten patients had a WBC
count of more than 10,000/mm3. The mean erythrocyte
sedimentation rate was 81 mm/h (72–117 mm/h). A
serological test for tularemia was positive in all patients.
The levels ranged from 1/320 to 1/1280. Although the
antibody titers were <1:160 in the first samplings in 3
patients, the antibody titers were 1/640 in repeated serum
samplings (Table).
Cultures of the aspirated materials and the materials
drained from the lesions of 10 patients showed no growing
microorganisms.
Nine patients were successfully treated with only
antimicrobial agents. At the end of 1 month of medical
treatment, fluctuation in the lymph nodes was detected
in 7 patients. Lymph nodes of those patients were excised
in order to prevent fistulization and scar formation.
Additionally, parotidectomy was performed in 1 patient.
No complications were noted. Neither septicemia nor
mortality was observed. At the end of at least a 6-month
follow-up period, all patients were completely symptomfree.

Figure. Mass in the neck region.
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Table. Clinical and laboratory findings and outcomes of patients.
Patient
no.

Sex

Age

Symptom
duration
(weeks)

1

M

18

2

2

M

25

3

M

4

ESR

Retention areas

MAT titer

Cured with
antibiotic only

Neck mass, pharyngitis

74

Upper jugular

1/640

Yes

3

Neck mass

72

Submandibular region

1/640

Yes

25

4

Neck mass

71

1/640

No

F

19

2

Neck mass, tonsillitis,
fever, parotid gland
involvement

89

Upper jugular,
parotid

1/640

Yes

5

M

40

1

Neck mass, pharyngitis,
fever

90

Upper jugular

1/1280

Yes

6

M

23

4

Neck mass

77

Upper jugular

1/1280

No

7

F

65

8

Neck mass

72

Upper jugular

1/1280

No

8

M

16

2

Neck mass, pharyngitis

84

Upper jugular

1/1280

Yes

9

M

33

3

Neck mass

82

Upper jugular

1/320

Yes

10

M

16

4

Neck mass

73

Submandibular region

1/1280

No

11

F

64

6

Neck mass

117

Upper jugular

1/1280

No

12

M

46

5

Neck mass

74

Upper jugular

1/320

No

13

F

42

3

Neck mass

84

Upper jugular

1/640

Yes

74

Upper jugular

1/640

Yes

Physical examination

14

M

24

1

Neck mass, tonsillitis,
skin rashes, fever

15

M

10

2

Neck mass

81

Upper jugular

1/320

Yes

16

M

73

4

Neck mass

82

Upper jugular

1/320

No

Abbreviations: ESR, erythrocyte sedimentation rate; MAT, microagglutination test.
Symptom duration: time before admission to hospital.

4. Discussion
In this study, we represented clinical data, management
strategies, and outcomes of 16 patients who were living
in rural areas of the city of Konya in the Central Anatolia
Region of Turkey.
Differential diagnosis is of great importance for patients
who apply to ear, nose, and throat clinics with complaints
of a neck mass. Upper respiratory infections, congenital
diseases, tuberculosis, primary neoplasms, and metastasis
are generally considered first, and tularemia is overlooked
if there are no epidemiological data (12). In general
practice, patients presenting symptoms of tonsillitis/
pharyngitis and presence of a cervical mass are first
generally treated with beta-lactam antibiotics. However, F.
tularensis releases beta-lactamase and is resistant to those

antimicrobial drugs (8). Likewise, all patients in our study
were referred to our center for the evaluation of intractable
neck mass after unsuccessful attempts of treatment with
beta-lactam antibiotics.
The diagnosis of tularemia may be difficult because
the results of routine laboratory tests and the radiological
features are nonspecific, such as increased WBC count
and acute phase reactants (15–17). F. tularensis is a
microorganism that grows poorly in standard culture
media. In our study, none of the cultures from 10 patients
demonstrated any growing microorganisms. Serological
tests aid the diagnosis of tularemia in the majority of cases
(2,18). Since the bacteria have a single antigenic type,
diagnosis through agglutination, microagglutination, and
enzyme-linked immunosorbent assay testing is possible.
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The serological positivity occurs during the first or second
week of disease in agglutination tests. Titers of ≥1:160 are
accepted as significant in agglutination tests and ≥1:128
is accepted as significant in microagglutination tests.
Additionally, a diagnosis can be made specifically by
polymerase chain reaction (3,18). The diagnoses of our
patients were made with the demonstration of a positive
tularemia agglutination test. However, the agglutination
test results were negative in the first samplings in 3 patients
in our study, but the antibody titers of those 3 patients were
1/640 in repeated serum samplings (Table). Hence, the
agglutination test should be repeated in suspected cases.
It is not completely clear how our patients were infected.
Previous data suggest that tularemia is mainly transmitted
through unmonitored spring water and consumption
of contaminated food in Turkey (2,3,18). Tularemia
outbreaks due to contaminated water usually occur in
fall and winter, whereas transmission via consumption of
hunted animals is more common in summer (1). Our cases
can be regarded as sporadic, because only 2 patients were
from the same family. There was no history of hunting,
contact with wild animals, or animal bites among our
patients. Hence, although all of the patients were infected
in the spring and summer months (May–August), the
most likely means of transmission in our patients was via
consumption of unmonitored spring water.
The most common symptoms in tularemia are neck
masses, sore throat, and fever (5,6). Other prominent
symptoms may include cough, myalgia, chest discomfort,
vomiting, sore throat, abdominal pain, and diarrhea, but
no clinical signs develop in nearly half of the infected
persons (5). In our series, although all patients had neck
masses and oropharyngeal stiffness, only 3 patients had
the complaint of fever and accompanying sore throat.
We think that the reason for this low frequency of those
symptoms among our patients is late referral to our clinic.
The most common site of involvement in the neck
is the upper jugular node group (5,9). Similar findings
were observed in our series (13 patients, 81%). All of our
patients had unilateral involvement. Likewise, unilateral
involvement was also reported in a majority of the cases
in the literature (9,19). Interestingly, 1 of our patients had
involvement of the right parotid gland, which has not been
reported before.
The first choice of antibiotics is streptomycin.
Gentamicin, tetracyclines, and ciprofloxacin are the

alternative agents (10). Antimicrobial therapy should be
continued for at least 10–14 days according to World Health
Organization guidelines (20). However, the duration of
the treatment could be adapted according to the clinical
course (21–23). We treated our patients for at least 3 weeks.
Early treatment with antimicrobial agents is more effective
and can prevent surgical interventions. However, surgical
interventions may be necessary in the case of the persistence
of cervical lymph nodes or in the case of abscess formation,
because wide scars may develop when lymph nodes are
drained spontaneously (7). In our series, 9 patients (56%)
were successfully treated only with antibiotics. However,
lymph node excision was performed in 7 patients, because
fluctuation in the lymph nodes was present at the end of
1 month of medical treatment, in order to achieve better
cosmetic appearance. In a study by Kızıl et al. (6), 6
patients underwent incision and drainage procedures, 5
patients underwent superselective neck dissection, and 8
patients had only medical treatment. It was seen that better
tissue healing with less scarring could be achieved in all
patients who underwent superselective neck dissection.
Additionally, parotidectomy was performed in 1 patient.
On the other hand, the need for surgical intervention was
quite variable in the literature, ranging between 34% and
75% in different reports (5,6,10,24). The difference between
those series is probably the variation between timing of
diagnosis and treatment. In our series, all the patients that
medical therapy start within 3 weeks recovered without
surgical interventions (Table).
Reported case series from the Central Anatolia Region
for oropharyngeal tularemia are limited. In the literature,
there are 3 case series for oropharyngeal tularemia from
Ankara Province. There is 1 case series from Kayseri and
Çankırı provinces (11,25,26). There is 1 case series from
Konya (27).
In summary, we herein reported the second series of
oropharyngeal tularemia from the city of Konya in the
Central Anatolia Region of Turkey. The clinical findings of
our patients were generally comparable to those previously
reported from Turkey. We could treat more than half of
our patients without surgical intervention. Interestingly,
medical therapy started within 3 weeks was successful
in all patients in our series. Hence, tularemia should
be considered in the differential diagnosis of patients
with neck mass in order to prevent diagnostic delay and
unnecessary surgical interventions.
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